<DOC>
	<DOCNO>NCT02183181</DOCNO>
	<brief_summary>Primary Objective : To access bioequivalence meloxicam capsule 15 mg ( Test , T ) meloxicam tablet 15mg ( Reference , R ) follow oral administration . Secondary Objective : To investigate safety tolerability meloxicam follow single dose meloxicam capsule 15 mg vs. meloxicam tablet 15 mg fast condition healthy male Taiwanese subject .</brief_summary>
	<brief_title>Bioequivalence Study Meloxicam Capsules 15 mg ( Mobic® Capsules 15 mg ) Versus Meloxicam Tablets 15 mg ( Mobic® Tablets 15 mg ) Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Meloxicam</mesh_term>
	<criteria>1 . Provision sign write informed consent enrolment study , ability communicate investigator , understand comply requirement study 2 . Healthy adult male , age 20 40 year old 3 . Body Mass Index ( BMI ) 18.5 25 , inclusive ( BMI calculate weight kilogram [ kg ] /height meters2 [ m2 ] ) . 4 . Physically mentally healthy subject confirm interview , medical history , clinical examination , chest xray electrocardiogram . 5 . No significant deviation biochemistry include : aspartate transaminase ( SGOT/AST ) , alanine transaminase ( SGPT/ALT ) , gammaglutamyltransferase ( GGT ) , alkaline phosphatase , total bilirubin , albumin , glucose , blood urea nitrogen ( BUN ) , creatinine , uric acid , total cholesterol triglyceride . 6 . No significant deviation normal hematology include : hemoglobin , hematocrit , white blood count ( WBC ) differential , red blood count ( RBC ) platelet count 7 . No significant deviation normal urinalysis include : pH , occult blood , glucose protein . 1 . History drug alcohol abuse within past one year 2 . Medical history allergic asthma sensitivity analogous drug 3 . Evidence chronic acute infectious diseases 4 week study 4 . Evidence clinical significant renal , cardiovascular , hepatic , hematopoietic , neurological , pulmonary gastrointestinal pathology . 5 . Ongoing peptic ulcer constipation 6 . Planned vaccination time course study . 7 . Taking clinical investigation drug 3 month study 8 . Use medication , include herb medicine vitamins 4 week study 9 . Blood donation 500 ml within past 3 month 10 . A positive prestudy Hepatitis B surface antigen positive Hepatitis C antibody result 11 . A positive test HIV antibody</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>